Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease.

Som Singh, Felix Yang, Andy Sivils, Victoria Cegielski, Xiang-Ping Chu

Biomolecules 2022 Jul 17

filter terms:

Alzheimer's disease remains a prevailing neurodegenerative condition which has an array physical, emotional, and financial consequences to patients and society. In the past decade, there has been a greater degree of investigation on therapeutic small peptides. This group of biomolecules have a profile of fundamentally sound characteristics which make them an intriguing area for drug development. Among these biomolecules, there are four modulatory mechanisms of interest in this review: alpha-, beta-, gamma-secretases, and amylin. These protease-based biomolecules all have a contributory role in the amyloid cascade hypothesis. Moreover, the involvement of various biochemical pathways intertwines these peptides to have shared regulators (i.e., retinoids). Further clinical and translational investigation must occur to gain a greater understanding of its potential application in patient care. The aim of this narrative review is to evaluate the contemporary literature on these protease biomolecule modulators and determine its utility in the treatment of Alzheimer's disease.

Citation

Som Singh, Felix Yang, Andy Sivils, Victoria Cegielski, Xiang-Ping Chu. Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease. Biomolecules. 2022 Jul 17;12(7)